Homologous recombination pathway alterations in basal-like breast cancer - Top-Institutions - MDSpire

Homologous recombination pathway alterations in basal-like breast cancer

  • By

  • Simon Aho

  • Boris Guyot

  • Véronique Maguer-Satta

  • June 18, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical Center

    Boston, MA

    Key Differentiators

    • Oncology

  • #2

    Harvard Medical School
    Harvard Medical School

    Boston, MA

    Key Differentiators

    • Oncology

  • #3

    Translational Breast Cancer Research Consortium
    Translational Breast Cancer Research Consortium

    N/A, N/A

    Key Differentiators

    • Oncology

  • #4

    Weill Cornell Medicine
    Weill Cornell Medicine

    New York, NY

    Key Differentiators

    • Oncology

  • #5

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

Original Source(s)

Homologous recombination pathway alterations in basal-like breast cancer

  • by Simon Aho, Boris Guyot, Véronique Maguer-Satta

  • June 18, 2026

Related Content

Polygenic Risk Scores for Breast Cancer Among African American Women With High Risk

Tumor microenvironment conversion through intelligent nanomedicine: a paradigm shift in overcoming chemoresistance

A Case Report of follicular dendritic cell sarcoma